Selegiline (Eldepryl), recently approved as an adjunct to levodopa-carbidopa (Sinemet), was administered to eight patients with Parkinson's disease in an open-label study. Many side effects were seen pertinent in particular to the elderly patient. Urinary retention was precipitated in two gentlemen. We advise that this medication be used with caution in the parkinsonian patient. (J Geriatr Psychiatry Neurol 1992;5:31–34).
Get full access to this article
View all access options for this article.
References
1.
1. Golbe LI: Deprenyl as symptomatic therapy in Parkinson's disease. Clin Neuropharmacol1988; 11:387–400.
2.
2. Elizan TS, Yahr MD, Moras DA, Mendoza MR, Pang S, Bodian CA: Arch Neurol1989; 46:1280–1283.
3.
3. Heinonen EH, Rinne UK: Selegiline in the treatment of Parkinson's disease. Acta Neurol Scand1989; 126:103–111.
4.
4. The Parkinson Study Group: Effect of Deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med1989; 321:1364–1371.
5.
5. Naranjo CA, Busto V, Sellers EM, et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30:239–245.
6.
6. Golbe LI: Long term efficacy and safety of Deprenyl (selegiline) in advanced Parkinson's disease. Neurology1989; 39:1109–1112.
7.
7. Menza MA, Golbe LI: Hypomania in a patient receiving Deprenyl (selegiline) after adrenal-striatal implantation for Parkinson's disease. Clin Neuropharmacol1988; 11:549–551.
8.
8. Pavlakis A, Siroky M, Goldstein I, et al: Neurourologic findings in Parkinson's disease. J Urol1983; 129:80–83.
9.
9. Sotolongo JR Jr: Voiding dysfunction in Parkinson's disease. Semin Neurol1988; 8:166–169.
10.
10. Berger Y, Blaivas JG, DeLaRocha ER, Salinas JM: Urodynamic findings in Parkinson's disease. J Urol1987; 138:836–838.
11.
11. Murdock MI, Olsson CA, Sax DS, Krane RJ: Effects of levodopa on the bladder outlet. J Urol1975; 113:803–805.
12.
12. Christmas TJ, Kempster PA, Chapple CR, et al: Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet1988; 2:1451–1453.
13.
13. Staskin DS, Vardi Y, Siroky MB: Post-prostatectomy continence in the parkinsonian patient: The significance of poor voluntary control. J Urol1988; 140:117–118.
